Santhera Pharmaceuticals Holding AG (SANN) — Cash Flow Quality Index
Santhera Pharmaceuticals Holding AG (SANN) has a Cash Flow Quality Index of 0.80x as of December 2023. Operating cash flow of CHF62.63 Million is below net income of CHF78.12 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SANN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Santhera Pharmaceuticals Holding AG Cash Flow Quality Index (2009–2023)
Historical Cash Flow Quality Index for Santhera Pharmaceuticals Holding AG across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SANN cash generation efficiency.
Annual Cash Flow Quality Index for Santhera Pharmaceuticals Holding AG (2009–2023)
Year-by-year earnings quality comparison for Santhera Pharmaceuticals Holding AG.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.86x | CHF47.27 Million | CHF54.78 Million | ▲ +111.3% |
| 2015 | -7.63x | CHF-22.39 Million | CHF2.93 Million | ▼ -853.2% |
| 2009 | -0.80x | CHF-20.75 Million | CHF25.92 Million | — |